MTOR and cancer: mTOR inhibitors have been used as monotherapy or combination therapy in preclinical and clinical trials to test its efficacy in treating various cancers; however, the effects were marginal, suggesting that the full therapeutic potential of targeting mTOR has not been exploited (19, 20).